Telemark Asset Management LLC Acquires New Shares in ASP Isotopes Inc. (NASDAQ:ASPI)

Telemark Asset Management LLC bought a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPIFree Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 1,700,000 shares of the company’s stock, valued at approximately $4,726,000.

A number of other institutional investors and hedge funds also recently modified their holdings of ASPI. Fielder Capital Group LLC acquired a new position in ASP Isotopes during the second quarter valued at approximately $55,000. Rhumbline Advisers acquired a new position in shares of ASP Isotopes in the 2nd quarter valued at $116,000. HTLF Bank grew its holdings in shares of ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after buying an additional 70,000 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of ASP Isotopes by 16.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock valued at $334,000 after buying an additional 17,159 shares in the last quarter. Finally, Virtu Financial LLC raised its stake in ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after buying an additional 69,176 shares during the period. 16.80% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on ASPI shares. Canaccord Genuity Group started coverage on ASP Isotopes in a research note on Friday, October 4th. They issued a “buy” rating and a $4.50 target price for the company. HC Wainwright lowered their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research note on Wednesday, August 7th. Finally, Canaccord Genuity Group restated a “buy” rating and set a $4.50 target price on shares of ASP Isotopes in a report on Friday, October 18th.

Check Out Our Latest Analysis on ASP Isotopes

ASP Isotopes Stock Performance

ASPI opened at $7.69 on Friday. The company has a market capitalization of $546.86 million, a price-to-earnings ratio of -11.93 and a beta of 3.88. The business’s 50-day moving average price is $4.75 and its two-hundred day moving average price is $3.80. ASP Isotopes Inc. has a 1 year low of $1.59 and a 1 year high of $9.33. The company has a debt-to-equity ratio of 2.06, a current ratio of 4.00 and a quick ratio of 4.00.

ASP Isotopes (NASDAQ:ASPIGet Free Report) last announced its earnings results on Monday, August 19th. The company reported ($0.24) earnings per share (EPS) for the quarter. The firm had revenue of $1.02 million during the quarter. ASP Isotopes had a negative net margin of 807.39% and a negative return on equity of 177.29%. Equities analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

About ASP Isotopes

(Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

Featured Articles

Want to see what other hedge funds are holding ASPI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ASP Isotopes Inc. (NASDAQ:ASPIFree Report).

Institutional Ownership by Quarter for ASP Isotopes (NASDAQ:ASPI)

Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.